These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 865652

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Problem of screening of antineoplastic drugs in tissue and cell cultures].
    Dobrynin IaV.
    Eksp Onkol; 1985; 7(2):9-15. PubMed ID: 4006851
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Some new aryl-sydnones: effects on murine tumours.
    Grynberg N, Gomes R, Shinzato T, Echevarria A, Miller J.
    Anticancer Res; 1992; 12(3):1025-8. PubMed ID: 1320354
    [Abstract] [Full Text] [Related]

  • 5. A methodological approach to the prediction of anticancer drug effect in humans.
    Durkin WJ, Ghanta VK, Balch CM, Davis DW, Hiramoto RN.
    Cancer Res; 1979 Feb; 39(2 Pt 1):402-7. PubMed ID: 761212
    [Abstract] [Full Text] [Related]

  • 6. Use of tritiated nucleotide incorporation for prediction of sensitivity of tumors to cytostatic agents.
    Volm M.
    Behring Inst Mitt; 1984 May; (74):273-84. PubMed ID: 6383325
    [Abstract] [Full Text] [Related]

  • 7. The primary cultures of animal ascites tumor cells growth in tubes in suspension as a model in the screening of antitumor agents.
    Ivanitskaya LP, Makukho LV.
    Neoplasma; 1975 May; 22(1):105-7. PubMed ID: 1153034
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potential of continuous tumour cell lines for establishing patterns of cross-resistance and collateral sensitivity in vitro.
    Hill BT.
    Drugs Exp Clin Res; 1986 May; 12(1-3):293-8. PubMed ID: 3732052
    [Abstract] [Full Text] [Related]

  • 12. [Anti-blastic properties of berberine and its derivatives].
    Shvarev IF, Tsetlin AL.
    Farmakol Toksikol; 1972 May; 35(1):73-5. PubMed ID: 5011522
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E, Teicher BA, Holden SA, Cathcart KN, Wang YY.
    Cancer Res; 1988 Nov 15; 48(22):6417-23. PubMed ID: 3180059
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alkylphosphonium salts as a new class of antitumor agents.
    Sanyal U, Chatterjee RS, Das SK, Chakraborti SK.
    Neoplasma; 1984 Nov 15; 31(2):149-55. PubMed ID: 6717684
    [Abstract] [Full Text] [Related]

  • 18. [The use of tumor cells for the primary screening of antineoplastic antibiotics].
    Ivanitskaia LP, Makukho LV.
    Antibiotiki; 1969 Nov 15; 14(3):221-5. PubMed ID: 5409249
    [No Abstract] [Full Text] [Related]

  • 19. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids.
    Shohat B, Schlesinger M, Grossowicz N, Lichtenstein N.
    Isr J Med Sci; 1972 Jan 15; 8(1):29-33. PubMed ID: 5067528
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.